1,579 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AMGN Amgen Inc. $200.81 $129.98B Buy
Article Searches
'Safer Dividend Picks From Barron's 10 For 2019 And Kiplinger's 12 Forever Stocks https://seekingalpha.com/article/4230525-safer-dividend-picks-barrons-10-2019-kiplingers-12-forever-stocks?source=feed Dec 28, 2018 - The December 17 issue of Barron's featured 10 favorite picks for the year ahead. While Kiplinger Today December 21 proclaimed 12 Stocks You Should Never Sell. This shows 'safer' picks.Of the 22 equiti
Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis http://www.zacks.com/stock/news/345011/spectrum-pharma-files-bla-for-neutropenia-candidate-rolontis?cid=CS-ZC-FT-345011 Dec 28, 2018 - Spectrum Pharma (SPPI) petitions for a BLA to the FDA regarding its lead pipeline candidate, Rolontis, to address chemotherapy-induced neutropenia in patients with breast cancer.
Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund https://seekingalpha.com/article/4230208-share-healthcare-biotech-gains-12-percent-yield-tekla-fund?source=feed_sector_healthcare Dec 27, 2018 - The biotech sector not only has helped to discover cures to difficult medical problems but also has outperformed the broader market. Tekla Healthcare Investors (HQH) is a CEF which provides investors
Four Dividend Growth Stocks To Think About For The New Year https://seekingalpha.com/article/4230207-four-dividend-growth-stocks-think-new-year?source=feed_all_articles Dec 26, 2018 - Broad market declines have increased the yields of some dividend growth stocks to values seen in the last recession.High quality companies with growing dividends are only periodically undervalued and
Barron's 10 Picks For 2019 Vs. Kiplinger's 12 Forever Stocks Show Target Gains And Losses https://seekingalpha.com/article/4229937-barrons-10-picks-2019-vs-kiplingers-12-forever-stocks-show-target-gains-losses?source=feed_all_articles Dec 24, 2018 - The December 17 issue of Barron's featured 10 favorite picks for the year ahead, while Kiplinger Today on December 21 proclaimed 12 Stocks You Should Never Sell.The top analyst-target-augured NET-GAIN
AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib http://www.zacks.com/stock/news/344208/abbvie-abbv-seeks-approval-for-ra-candidate-upadacitinib?cid=CS-ZC-FT-344208 Dec 21, 2018 - AbbVie (ABBV) submits regulatory applications in the United States and EU for upadacitinib, for the treatment of adult patients with moderate to severe rheumatoid arthritis.
Dividends Are The Only Defense In This Turbulent Market https://seekingalpha.com/article/4229589-dividends-defense-turbulent-market?source=feed Dec 21, 2018 - The fourth quarter of 2018 has been challenging for the best investors. Just look at the dismal performance of hedge funds. Even the simplest of investments, like an S&P 500 ETF, have performed po
Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review http://www.zacks.com/stock/news/344112/mercks-sbla-for-keytruda-in-lung-cancer-gets-extended-review?cid=CS-ZC-FT-344112 Dec 21, 2018 - FDA extends review period for label expansion application for Merck's (MRK) Keytruda in first-line lung cancer by three months. A decision is now expected in April 2019.
Amgen Set For 2019 With Aimovig, Repatha, And Rest Of Pipeline https://seekingalpha.com/article/4229478-amgen-set-2019-aimovig-repatha-rest-pipeline?source=feed_sector_healthcare Dec 20, 2018 - Aimovig should drive Amgen revenue higher in Q4.2019 should be a solid year.Watch for 2019 guidance in January.
Amgen Applies for Expanded Use of Nplate in US http://www.gurufocus.com/news/789148/amgen-applies-for-expanded-use-of-nplate-in-us Dec 20, 2018 - Amgen Applies for Expanded Use of Nplate in US, Stocks: AMGN, release date:Dec 20, 2018

Pages: 12345678...158

<<<Page 3>